جاهز للتشغيل
جاهز للتشغيل
A recent study has shown that the Human Papillomavirus (HPV) vaccine reduces the risk of death from cervical cancer by 63%, having prevented the deaths of around 200 young women since the vaccination program began in Britain in 2008. Researchers confirmed that increasing vaccination coverage could prevent more deaths in the future, despite a decline in uptake following the COVID-19 pandemic.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading